Skip to main content

Advertisement

Log in

IgG isotype to C-terminal 19 kDa of Plasmodium vivax merozoite surface protein 1 among subjects with different levels of exposure to malaria in Brazil

  • Original Paper
  • Published:
Parasitology Research Aims and scope Submit manuscript

Abstract

Subclasses of antibodies to the C-terminal 19 kDa fragment of the Plasmodium vivax merozoite surface protein 1 (PvMSP-119) were assessed among subjects with distinct degrees of malaria exposure in the Brazilian endemic area. The PvMSP-119 specific IgG1and IgG3 levels were low among subjects with long-term exposure (~19 years) when compared to subjects less and sporadically exposed (<1 year). No statistically difference was observed in IgG subclass distribution of antibodies from symptomatic Plasmodium-infected patients, asymptomatic parasite carriers and non-infected subjects living in a same mesoendemic area. Subjects briefly exposed to a P. vivax outbreak living in a rural community outside the endemic area were also evaluated to measure the persistence of specific antibodies. IgG anti-PvMSP-119 antibodies persisted in 40% of the subjects who had had malarial symptoms 8 months before and decreased after 7 years (28%). Specific IgG1 were the predominant isotype. Our study emphasizes the highly immunogenicity of the PvMSP-119 and points toward its possible use as a potential malaria vaccine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Blackman MJ, Heidrich H, Donachie S, Mcbride JS, Holder AA (1990) A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J Exp Med 172:379–382

    Google Scholar 

  • Blackman MJ, Ling IT, Nicholls SC, Holder AA (1991) Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. Mol Biochem Parasitol 49:29–33

    Google Scholar 

  • Braga EM, Fontes CJF, Krettli AU (1998) Persistence of humoral response against sporozoite and blood-stage malaria antigens 7 years after a brief exposure to Plasmodium vivax. J Infect Dis 177:1132–1135

    Google Scholar 

  • Braga EM, Barros RM, Reis TA, Fontes CJF, Morais CG, Martins MS, Krettli AU (2002) Association of the IgG response to Plasmodium falciparum merozoite protein (C-terminal 19 kD) with clinical immunity to malaria in the Brazilian Amazon region. Am J Trop Med Hyg 66:461–466

    Google Scholar 

  • Branch OH, Oloo AJ, Nahlen BL, Kaslow D, Lal AA (2000) Anti-merozoite surface protein-1 19-kDa IgG in mother-infant pairs naturally exposed to Plasmodium falciparum: subclass analysis with age, exposure to asexual parasitemia, and protection against malaria. V. The Asembo Bay cohort project. J Infect Dis 181:1746–1752

    Google Scholar 

  • Cunha MG, Rodrigues MM, Soares IS (2001) Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate MSP119 expressed in distinct bacterial vectors. Vaccine 20:385–396

    Google Scholar 

  • Dekker C, Uthaipibull C, Calder LJ, Lock M, Grainger M, Morgan WD, Dodson GG, Holder AA (2004) Inhibitory and neutral antibodies to Plasmodium falciparum MSP119 form ring structures with their antigen. Mol Biochem Parasitol 137:143–149

    Google Scholar 

  • Dodoo D, Theander TG, Kurtzhals JA, Koram K, Riley E, Akanmori BD, Nkrumah FK, Hviid L (1999) Levels of antibody to conserved parts of Plasmodium falciparum merozoite surface protein 1 in Ghanaian children are not associated with protection from clinical malaria. Infect Immun 67:2131–2137

    Google Scholar 

  • Egan AE, Morris J, Barnish G, Allen S, Greenwood BM, Kaslow DC, Holder A, Riley EM (1996) Clinical immunity P. falciparum malaria is associated with serum antibodies to the 19 kDa C-terminal fragment of the merozoite surface antigen PfMSP1. J Infect Dis 173:765–769

    Google Scholar 

  • Engers HD, Godal T (1998) Malaria vaccine development: current status. Parasitol Today 14:56–64

    Google Scholar 

  • Fontes CJF (2001) Malária assintomática em áreas de garimpo no Brasil: estudos de fatores de risco. Belo Horizonte: Faculdade de Medicina da Universidade Federal de Minas Gerais. Belo Horizonte, PhD Thesis, p 178

    Google Scholar 

  • Fontes CJF, Bathurst I, Krettli AU (1991) Plasmodium vivax sporozoite antibodies in individuals exposed during a single malaria outbreak in a non-endemic area. Am J Trop Med Hyg 44:28–33

    Google Scholar 

  • Fraser T, Michon P, Barnwell JW, Noe AR, Al-Yaman F, Kaslow DC, Adams JH (1997) Expression and serologic activity of a soluble recombinant Plasmodium vivax Duffy binding protein. Infect Immun 65:2772–2777

    Google Scholar 

  • Han HJ, Park SG, Kim SH, Hwang SY, Han J, Traicoff J, Kho WG, Chung JY (2004) Epidermal growth factor-like motifs 1 and 2 of Plasmodium vivax merozoite surface protein 1 are critical domains in erythrocyte invasion. Biochem Biophys Res Commun 320:563–570

    Google Scholar 

  • Holder AA (1988) The precursor to major merozoite surface antigens: structure and role in immunity. Prog Allergy 41:72–97

    Google Scholar 

  • Holder AA, Guevara Patino JA, Uthaipibull C, Syed SE, Ling IT, Scott-Finnigan T, Blackman MJ (1999) Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria. Parassitologia 41:409–414

    Google Scholar 

  • Lim KJ, Park JW, Yeom JS, Lee YH, Yoo SB, Oh JH, Sohn MJ, Bahk YY, Kim YS (2004) Humoral responses against the C-terminal region of merozoite surface protein 1 can be remembered for more than 30 years in persons exposed to Plasmodium vivax. Parasitol Res 92:384–389

    Google Scholar 

  • Marques AC (1987) Human migration and the spread of malaria in Brazil. Parasitol Today 3:166–170

    Google Scholar 

  • O’Donnell RA, De Koning-Ward TF, Burt RA, Bockarie M, Reeder JC, Cowman AF, Crabb BS (2001) Antibodies against merozoite surface protein MSP-119 are a major component of the invasion-inhibitory response in individuals immune to malaria. J Exp Med 193:1403–1412

    Google Scholar 

  • Parish CR (1972) The relationship between humoral and cell-mediated immunity. Transplant Rev 13:35–66

    Google Scholar 

  • Park JW, Moon SH, Yeom JS, Lim KJ, Sohn MJ, Jung WC, Cho YJ, Jeon KW, Ju W, Ki CS, Oh MD, Che KW (2001) Naturally acquired antibody responses to the C-terminal region of the merozoite surface protein 1 of Plasmodium vivax in Korea. Clin Diagn Lab Immunol 8:14–20

    Google Scholar 

  • Pasay MC, Cheng Q, Rzepczyk C, Saul A (1995) Dimorphism of the C terminus of the Plasmodium vivax merozoite surface protein 1. Mol Biochem Parasitol 70:217–219

    Google Scholar 

  • Riley EM, Wagner GE, Ofori MF, Wheeler JG, Akanmori BD, Tetteh K, McGuinness D, Bennett S, Nkrumah FK, Anders RF, Koram KA (2000) Lack of association between maternal antibody and protection of African infants from malaria infection. Infect Immun 68:5856–5863

    Google Scholar 

  • Sawyer D (1993) Economic and social consequences of malaria in new colonization projects in Brazil. Soc Sci Med 37:1131–1136

    Google Scholar 

  • Scopel KKG, Fontes CJF, Nunes AC, Horta MF, Braga EM (2004) Low sensitivity of nested PCR using Plasmodium DNA extracted from stained thick blood smears: an epidemiological retrospective study among subjects with low parasitemias in a Brazilian Amazon endemic area. Malar J 3:8

    Google Scholar 

  • Soares IS, Levitus G, Souza JM, Del Portillo HA, Rodrigues MM (1997) Acquired immune responses to the N- and C-terminal regions of P. vivax merozoite surface protein 1 in individuals exposed to malaria. Infect Immun 65:1606–1614

    Google Scholar 

  • Soares IS, Oliveira SG, Souza JM, Rodrigues MM (1999a) Antibody response to the N- and C-terminal regions of the Merozoite surface protein 1 in individuals living in an area of exclusive transmission of Plasmodium vivax malaria in the north of Brazil. Acta Trop 72:13–24

    Google Scholar 

  • Soares IS, Cunha MG, Silva MN, Souza JM, Del Portillo HA, Rodrigues MM (1999b) Longevity of the naturally acquired antibody responses to the N- and C-terminal regions of P. vivax MSP1. Am J Trop Med Hyg 60:357–363

    Google Scholar 

  • Soares IS, Barnwell JW, Ferreira MU, Cunha MG, Laurino JP, Castilho BA, Rodrigues MM (1999c) A Plasmodium vivax vaccine candidate displays limited allele polymorphism, which does not restrict recognition by antibodies. Mol Med 5:459–470

    Google Scholar 

  • Taylor-Robinson AW (1998) Immunoregulation of malarial infection: balancing the vices and virtues. Int J Parasitol 28:135–148

    Google Scholar 

Download references

Acknowledgments

This work was financially supported by Fundação de Amparo à Pesquisa do Estado de Minas Gerais FAPEMIG (grant no. CBB2323/97). Informed consent was obtained from subjects according to the Universidade Federal de Minas Gerais Ethics Committee (15 April 1998) and Fundação Oswaldo Cruz Ethics Committee (26 November 1994).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Érika Martins Braga.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morais, C.G., Soares, I.S., Carvalho, L.H. et al. IgG isotype to C-terminal 19 kDa of Plasmodium vivax merozoite surface protein 1 among subjects with different levels of exposure to malaria in Brazil. Parasitol Res 95, 420–426 (2005). https://doi.org/10.1007/s00436-005-1314-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00436-005-1314-x

Keywords

Navigation